Johnson and Johnson two-dose vaccine against Ebola safe, claims study MD Bureau16 Sep 2021 5:00 AM GMTLondon: The two-dose vaccine against Ebola virus developed by US drug maker Johnson and Johnson is safe, well tolerated and produces a strong immune re...
JnJ HIV vaccine fails Imbokodo trial ruchika1 Sep 2021 11:24 AM GMTThe Imbokodo study showed a 25.2% vaccine efficacy, based on which, the drugmaker said the study will not continue.
Pfizer COVID vaccine for 5-12 years likely to get nod by October: Ex-USFDA Chief MD Bureau30 Aug 2021 7:02 AM GMTWashington: US drug maker Pfizer's Covid-19 vaccine is likely to get authorisation for providing vaccines to children aged between 5 to 12 by October, ...
Second dose provides strong boost against Covid-19: JnJ MD Bureau27 Aug 2021 3:30 AM GMTWashington: The second dose of Johnson & Johnson's Covid-19 vaccine generates a strong immune response against the deadly virus among people previo...
JnJ ORSL Matter: Delhi HC asks FSSAI, Delhi Govt to decide ruchika26 Aug 2021 12:03 PM GMTNew Delhi: The Delhi High Court Thursday asked the authorities to consider as representation a PIL alleging the deliberate mis-labelling of products as...
ORS or not ORS? PIL seeks prohibition of JnJ ORSL brand questioning its composition Medical Dialogues Team25 Aug 2021 11:35 AM GMTNew Delhi: Alleging that Johnson and Johnson (JnJ) has been deceptively selling ORSL drinks as ORS health formula, a petition has been filed in the Del...
JnJ eyes CDSCO nod for single shot COVID vaccine trials in 12-17 year olds MD Bureau20 Aug 2021 6:10 AM GMTNew Delhi: The American-based pharma major Johnson & Johnson (J&J) has applied to the Central Drugs Standard Control Organisation (CDSCO) ...
Johnson and Johnson Rilematovir gets CDSCO panel okay for phase 3 trial Medical Dialogues Team18 Aug 2021 10:48 AM GMTNew Delhi: Global pharmaceuticals major Johnson and Johnson (JnJ) has got a go ahead from the Subject Expert Committee (SEC) of the Central Drugs Stand...
JnJ cancer drug Amivantamab gets CDSCO panel okay with waiver of local phase 3,4 trials Medical Dialogues Team14 Aug 2021 9:55 AM GMTNew Delhi: Considering an unmet medical need in the country, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDS...
JnJ gets DCGI emergency use approval for single dose COVID vaccine ruchika7 Aug 2021 11:21 AM GMTNew Delhi: Johnson & Johnson's single-dose COVID-19 vaccine has been given Emergency Use approval in India, Union Health minister Mansukh Mandaviya...
Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension ruchika2 Aug 2021 6:45 AM GMTTitusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has appro...
Covid-19: CDSCO panel nod to trial of mixing Covaxin, Covishield doses Medical Dialogues Bureau31 July 2021 8:15 AM GMTNew Delhi: An expert panel of India's central drug authority (Central Drugs Standard Control Organisation) on Thursday recommended granting permission ...
